Products
3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid
  • 3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid

3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid

Model: 1599477-75-4
3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid is a highly elaborated spirocyclic phenylacetic acid that integrates an electron‑deficient 2‑chloro‑5‑(trifluoromethoxy)phenyl ring, a basic spiro‑piperidine nitrogen, and a flexible acetic acid side chain attached to the distal cyclohexane ring. The simultaneous presence of chlorine and a trifluoromethoxy group on the aromatic portion lowers electron density, enhances lipophilicity, and improves metabolic stability—attributes that often translate into improved target engagement and sustained pharmacokinetics. The spiro junction locks the relative orientation of the aromatic pharmacophore and the carboxylate, producing a well‑defined exit vector that allows medicinal chemists to precisely position the acid group within a binding site, all while maintaining the three‑dimensionality that differentiates this molecule from flat, aromatic‑rich acids.

3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid is a next‑generation spiro‑acid building block designed to populate the under‑explored chemical space between classic phenylacetic acids and fully saturated spiro motifs. The acetic acid handle of 3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid can be directly employed as a carboxylate pharmacophore or readily converted into amides, esters, and hydroxamic acids, making the compound a versatile late‑stage intermediate for parallel library synthesis. In drug discovery programmes targeting G‑protein coupled receptors and ion channels, 3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid has demonstrated value as a rigid scaffold that correctly pre‑positions the acid group relative to the halogen‑substituted aromatic ring, helping to improve selectivity profiles. Because 3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid is a fully synthetic entity with a scalable supply chain, it supports everything from milligram‑scale screening to multi‑kilogram preclinical development under consistent quality control.


Product Parameters

Parameter

Specification

Product Name

3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid

CAS Number

1599477-75-4

Molecular Formula

C₁₉H₂₃ClF₃NO₃

Molecular Weight

405.84 g/mol

Purity (HPLC)

≥95% (typical)

Physical Form

Solid

Appearance

Off-white to pale yellow solid

Melting Point

148–153 °C (dec.)

Boiling Point

503.2 ± 50.0 °C (predicted)

Density

1.30 ± 0.1 g/cm³ (predicted)

Flash Point

258.1 ± 30.1 °C (predicted)

LogP

4.25 ± 0.33 (predicted)

pKa (strongest acidic)

4.57 ± 0.10 (predicted, carboxylic acid)

Solubility

Soluble in DMSO, DMF, ethanol; slightly soluble in water (solubility increases above pH 5)

Storage Condition

Store at -20°C


Why Cosperpharm? – Our Competitive Advantages

Advantage

Detail

Production Strength

GMP-certified campus spanning 100+ mu, 3 multi-purpose workshops, 6 D-grade clean zone production lines, and 150+ reactors (20L–5000L), supporting high/low temp, anaerobic & hydrogenation; kg to ton scale production.

Fast Delivery

R&D samples: one week; commercial orders: 1–2 months after payment. Express (DHL/FedEx) or air/sea freight available.

Global Partners

Trusted by 30+ pharmaceutical companies in USA, Europe, India, Brazil, and Southeast Asia; long-term cooperation with generic drug manufacturers, CROs, and impurity standard distributors.

Licensed Exporter

Valid drug import/export license — no compliance delays.

Dual Quality Grades

Both research/pharma grade(≥98%)and high-purity impurity grade(≥99%)available to meet diverse customer needs.


FAQ

Q1: Does this compound contain any stereocenters?

A: No. The spiro‑piperidine ring and the cyclohexane‑acetic acid fragment are both symmetric; the molecule is achiral and obtained as a single entity.

Q2: How should I dissolve it for biological assays?

A: Prepare a concentrated stock solution in DMSO (10–50 mM) and dilute into assay buffer. The free acid is slightly soluble in water at neutral pH but becomes more soluble as the pH rises above its pKa (~4.6). Ensure the final DMSO concentration does not exceed 1% in cellular assays.


Quality Assurance at Cosperpharm

Each batch undergoes:

● Gas chromatography (GC) – purity ≥97.0%

● Non‑aqueous titration – purity ≥97.0%

● Refractive index – confirmatory analysis

● ¹H NMR – structural verification

● Appearance – colorless to light yellow to light orange clear liquid

A comprehensive COA, MSDS (with full GHS information), and certificate of origin accompany every shipment.


Contact Us

Looking for a spiro‑acid that brings both rigidity and the right halogen pattern to your binding pocket? Contact Cosperpharm today to discuss your requirements for 3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid. From initial profiling quantities to full‑scale campaign batches, we are ready to provide the quality, documentation, and technical insight that your project needs. Let’s talk about how we can help you move from concept to candidate—fast and reliably.


Hot Tags: 3-[2-Chloro-5-(trifluoromethoxy)phenyl]-3-azaspiro[5.5]undecane-9-acetic acid, China, Manufacturer, Supplier, Factory
Send Inquiry
Contact Info
For inquiries about our products or pricelist, please leave your email to us and we will be in touch within 24 hours.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.Privacy Policy
RejectAccept